What Is Relapsing Polychondritis?

Relapsing polychondritis (RP) is a systemic inflammatory disease of unknown etiology that can be fatal. The disease affects multiple organs, particularly cartilaginous structures such as the ears, nose, airways and joints as well as eyes, skin, heart valves and brain.

Learn More

RP PATIENT SURVEY: AUTOIMMUNE AND COVID-19

When it comes to how the rapidly spreading coronavirus (COVID-19) is affecting people with vasculitis, medical experts agree there are more questions than answers – at least right now.

To address that concern, the Relapsing Polychondritis Foundation, the Vasculitis Foundation (VF),  and the Vasculitis Patient Powered Research Network (VPPRN) have teamed up with partners in the Autoimmune Research Collaborative (ARC) to launch a new COVID-19 patient study.

We want to know your concerns.  Please participate in the patient research survey: Autoimmune and COVID-19.  Your participation will help researchers, clinicians and other patients better understand how people with relapsing polychondritis and other forms of vasculitis are dealing with COVID-19 / the novel coronavirus.

To get started, please go to: www.vasculitisfoundation.org/rp_vasccovid-19/

FOLLOW US ON SOCIAL MEDIA

Patient Information

Whether you are a newly diagnosed patient, spouse or significant other, parent or other family member of a patient, we are here to help.

We are a patient-founded and patient-driven 501(c)3 non-profit foundation which strives to raise awareness about RP and educate the public, as well as represent patients to the global medical community and support medical research toward a cure.

Learn More

Latest Foundation News

We strive to provide news related to our progress and efforts as a foundation, important updates and accomplishments of our affiliated and partnership organizations as well as pertinent news we believe impacts patients within the autoimmune disease community and beyond. The sharing or posting of any news does not imply an endorsement of related statistics or confirmation of medical research or information.

View More

Race For RP

Driving Awareness

The Race for RP supports research, awareness programs, and care for those who are affected by relapsing polychondritis (“RP”) and related diseases. Our drivers our passionate about raising awareness for the autoimmune disease community and RP. While our drivers race for RP, our organization is speeding to find a cure. We’re working to facilitate research and studies to help diagnose, prevent and cure Relapsing Polychondritis, and its related diseases. Whether you’re a professional driver, amateur racer, or a weekend warrior passionate about racing, we encourage you to connect with us to discover how you can Race for RP.

Learn More

RP Foundation on Social Media

Race for RP - "Relapsing Polychondritis"Congratulations, Jon Morley and Gavin Ernstone, for your P3 podium finish in TCR in the No. 61 @RoadShaggerRacing Simply Vegas Audi RS3 LMS TCR. ⠀⠀⠀⠀⠀⠀⠀⠀ #RaceforRP #IMSA #MidOhio #Audi #AudiRS3 #AudiRS3LMS #TCR #Motorsports ... See MoreSee Less

4 days ago

Race for RP - "Relapsing Polychondritis"Way to go!! A P2 podium finish for Jeff @Westphalracing and @tylermcquarrie in the No. 39 @CarBahn_Autoworks @PeregrineRacingTeam Audi R8 GT4. ⠀⠀⠀⠀⠀⠀⠀⠀ #RaceforRP #RelapsingPolychondritis #IMSA #MidOhio #Audi #AudiR8 #GT4 ... See MoreSee Less

4 days ago

Image attachmentImage attachment

Race for RP - "Relapsing Polychondritis"An incredible come from behind WIN for Kyle Marcelli and Nate Stacy Racing in the No. 60 Race for RP KohR Motorsports Aston Martin Vantage GT4 at @officialmidohio. ⠀⠀⠀⠀⠀⠀⠀⠀ #RaceforRP #IMSA #AstonMartin #AstonMartinRacing #MidOhio #Motorsports @astonmartinracingofficial @MichelinUSA ... See MoreSee Less

4 days ago

Load more

Excellent update from @Mid_Ohio with Race for RP driver, Jon Morley, as he gets set to race with Gavin Ernstone in the No. 61 RSR Simply Vegas Audi RS3 TCR.

Thank you, RSR, for driving awareness about Relapsing Polychondritis.
⠀⠀⠀⠀⠀⠀⠀⠀
#RaceforRP #IMSA #MidOhio #IMPC

Load More...